image
Cogent Biosciences, Inc. COGT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 8.9
-7.77 %
$ 983 M
Market Cap
-3.59
P/E
BALANCE SHEET
313 M ASSETS
4.20%
Growth Rates
1Year 4.20%
3Years 7.70%
5Years 29.54%
7Years 22.54%
10Years 0.00%
55.6 M LIABILITIES
23.43%
Growth Rates
1Year 23.43%
3Years 50.72%
5Years 16.71%
7Years 13.34%
10Years 0.00%
258 M EQUITY
0.81%
Growth Rates
1Year 0.81%
3Years 3.18%
5Years 33.75%
7Years 25.56%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Cogent Biosciences, Inc.
image
Current Assets 271 M
Cash & Short-Term Investments 266 M
Receivables 0
Other Current Assets 5.06 M
Non-Current Assets 42.7 M
Long-Term Investments 7.46 M
PP&E 30.3 M
Other Non-Current Assets 4.86 M
Current Liabilities 38.2 M
Accounts Payable 10.7 M
Short-Term Debt 2.77 M
Other Current Liabilities 24.7 M
Non-Current Liabilities 17.5 M
Long-Term Debt 17.5 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
ASSETS
Cash & Cash Equivalents 53.2 139.9 219.7 242.2 37.4 55.7 28.3 41.3 90.5
Short Term Investments 212.5 119.4 0 0 0 22.9 12.7 27.2 0
Receivables 0 0 0 0 2.0 1.7 0.8 0.9 0.3
Inventory 0 0 0 0 0 0 75 K 0 0
Other Current Assets 5.1 5.7 5.9 5.4 2.3 1.5 0.6 0.3 0.3
Total Current Assets 270.8 265.0 222.6 244.9 40.6 81.0 42.4 69.7 91.1
PP&E 30.3 31.1 4.5 4.7 7.2 3.3 4.1 4.6 2.4
Intangible Assets 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0
Long Term Investments 7.5 0 1.3 1.3 1.3 1.3 1.3 1.3 1.3
Other Long Term Assets 4.9 4.7 3.7 0 0.4 0.4 1.4 0 0
Other Assets 0 0 0 0 0 0 0 0 0
Total Assets 313.4 300.8 232.1 250.9 49.4 85.9 49.1 75.5 94.8
LIABILITIES
Accounts Payable 10.7 5.8 3.5 0.7 3.2 1.5 1.3 1.5 1.4
Short Term Debt 2.8 2.8 4.6 4.1 3.2 0 0 0 1
Other Current Liabilities 24.7 18.2 8.9 8.3 5.5 5.5 3.0 1.3 0.6
Total Current Liabilities 38.2 26.8 17.1 13.1 13.2 24.9 11.2 8.7 7.3
Long Term Debt 17.5 18.2 0.8 3.2 4.4 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0.7 0.9 0.9 0.7
Total Liabilities 55.6 45.1 17.9 16.2 17.7 25.7 20.8 23.2 25.3
EQUITY
Common Stock 86 K 70 K 44 K 32 K 30 K 30 K 10 K 10 K 16 K
Retained Earnings (603.6) (411.2) (271.0) (198.7) (123.9) (92.1) (51.3) (25.8) (7.7)
Other Accumulative Comprehensive Income/Loss 0.2 (0.1) 0 0 0 12 K 16 K 24 K 16 K
Total Equity 257.8 255.7 214.2 234.7 31.8 60.2 28.3 52.4 69.5
Total Liabilities and Equity 313.4 300.8 232.1 250.9 49.4 85.9 49.1 75.5 94.8
SHARES OUTSTANDING
Common Shares Outstanding 79.7 58.7 38.7 11.1 7.6 6.2 7.4 5.9 5.9